| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0065-2164(08)70253-3 |
| P698 | PubMed publication ID | 1642155 |
| P2093 | author name string | J. M. Birmingham | |
| S. C. Jong | |||
| P2860 | cites work | Triterpenes from Ganoderma lucidum | Q105135538 |
| Central actions of adenosine, a nucleotide ofGanoderma lucidum | Q105192702 | ||
| New terpenoids, ganolucidic acid D, ganoderic acid L, lucidone C and lucidenic acid G, from the fungus Ganoderma lucidum. | Q115950950 | ||
| New bitter C27 and C30 terpenoids from the fungus Ganoderma lucidum (Reishi). | Q120073746 | ||
| Polysaccharides in fungi. XIII. Antitumor activity of various polysaccharides isolated from Dictyophora indusiata, Ganoderma japonicum, Cordyceps cicadae, Auricularia auricula-judae, and Auricularia species | Q28275383 | ||
| Isolation and characterization of antitumor active β-d-glucans from the fruit bodies of Ganoderma applanatum | Q29031399 | ||
| Noncytotoxic, antitumor polysaccharides | Q40569771 | ||
| Effect of polysaccharides from Ganoderma applanatum on immune responses. I. Enhancing effect on the induction of delayed hypersensitivity in mice | Q40724262 | ||
| Anti-allergic constituents in the culture medium of Ganoderma lucidum. (II). The inhibitory effect of cyclooctasulfur on histamine release | Q43558350 | ||
| Effects of the extracts of Ganoderma lucidum on blood glucose level in rats | Q44039174 | ||
| Antitumor activity of Sarcodon aspratus (Berk.) S. Ito and Ganoderma lucidum (Fr.) Karst | Q45017857 | ||
| Anti-allergic constituents in the culture medium of Ganoderma lucidum. (I). Inhibitory effect of oleic acid on histamine release | Q47382163 | ||
| Isolation of an inhibitor of platelet aggregation from a fungus, Ganoderma lucidum | Q47424829 | ||
| Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypertensive rats (SHR) | Q68049904 | ||
| The biologically active constituents of Ganoderma lucidum (Fr.) Karst. Histamine release-inhibitory triterpenes | Q68942535 | ||
| Mechanisms of hypoglycemic activity of ganoderan B: a glycan of Ganoderma lucidum fruit bodies | Q69552120 | ||
| Ganoderic acid and its derivatives as cholesterol synthesis inhibitors | Q69648955 | ||
| Hypoglycemic actions of some heteroglycans of Ganoderma lucidum fruit bodies | Q69795177 | ||
| Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum | Q70150527 | ||
| Polysaccharides in fungi. XIV. Anti-inflammatory effect of the polysaccharides from the fruit bodies of several fungi | Q70476078 | ||
| Antitumor Polysaccharides from Some Polyporaceae, Ganoderma applanatum (PERS.) PAT and Phellinus linteus (BERK. et CURT) AOSHIMA | Q70518012 | ||
| Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum | Q71105097 | ||
| Structures of Ganoderic Acid A and B, Two New Lanostane Type Bitter Triterpenes fromGanoderma lucidum (FR.) KARST. | Q78234437 | ||
| Ganoderic acid D, E, F, and H and lucidenic acid D, E, and F, new triterpenoids from Ganoderma lucidum. | Q78435470 | ||
| Ganoderic acid G and I and ganolucidic acid A and B, new triterpenoids from Ganoderma lucidum. | Q78435475 | ||
| Structures of new terpenoid constituents of Ganoderma lucidum (Fr.) KARST (Polyporaceae). | Q78435485 | ||
| Ganoderic acids T, S and R, new triterpenoids from the cultured mycelia of Ganoderma lucidum. | Q78435490 | ||
| Constituents of the fungus Ganoderma lucidum (Fr.) Karst. I Structures of ganoderic acids C2, E, I, and K, lucidenic acid F and related compounds. | Q78435499 | ||
| New bitter C27 and C30 terpenoids from the fungus Ganoderma lucidum (Reishi). | Q78436255 | ||
| Ganoderiol A and B, new triterpenoids from the fungus Ganoderma lucidum (Reishi). | Q78436280 | ||
| Two New Lanostanoids from Ganoderma lucidum | Q78441977 | ||
| Two New Triterpenes of the Fungus Ganoderma lucidum | Q78441999 | ||
| Isolation and Hypoglycemic Activity of Ganoderans A and B, Glycans of Ganoderma lucidum Fruit Bodies1 | Q79883605 | ||
| Les acides ganoderiques tàz : triterpenes cytotoxiques de Ganoderma lucidum (Polyporacée) | Q103817435 | ||
| Bitter triterpenoids from the fungus Ganoderma applanatum | Q104104078 | ||
| Changes of the triterpenoid patterns during formation of the fruit body in Ganoderma lucidum | Q104389210 | ||
| Novel triterpenoids from the mycelial mat at the previous stage of fruiting of Ganoderma lucidum. | Q104394054 | ||
| Novel triterpenoids from the fungus Ganoderma lucidum. | Q104864808 | ||
| Ganoderic acid derivatives, highly oxygenated lanostane-type triterpenoids, from Ganoderma lucidum | Q104884511 | ||
| A ganoderic acid derivative, a highly oxygenated lanostane-type triterpenoid from Ganoderma lucidum | Q104886658 | ||
| New terpenoids from Ganoderma lucidum and their bitterness. | Q104913401 | ||
| Novel triterpenoids and a steroid from the fungus Ganoderma lucidum. | Q104913993 | ||
| Ganoderic acid derivatives and ergosta-4,7,22-triene-3,6-dione from Ganoderma lucidum | Q104917086 | ||
| Triterpenoids from the fungus Ganoderma lucidum | Q104917981 | ||
| Constituents of the fungus Ganoderma lucidum (Fr.) Karst. II Structures of ganoderic acids F, G, and H, lucidenic acids D2 and E2, and related compounds. | Q104917982 | ||
| Triterpenes in Ganoderma lucidum | Q104923723 | ||
| New terpenoids, ganoderic acid J and ganolucidic acid C, from the fungus Ganoderma lucidum. | Q104963896 | ||
| Constituents of the fungus Ganoderma lucidum (Fr.) Karst. III Structures of ganolucidic acids A and B, new lanostane-type triterpenoids. | Q105000344 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Basidiomycota | Q174698 |
| P304 | page(s) | 101-134 | |
| P577 | publication date | 1992-01-01 | |
| P1433 | published in | Advances in Applied Microbiology | Q15753069 |
| P1476 | title | Medicinal benefits of the mushroom Ganoderma | |
| Medicinal Benefits of the Mushroom Ganoderma | |||
| P478 | volume | 37 |
| Q46787185 | An improved HPLC-DAD method for quantitative comparisons of triterpenes in Ganoderma lucidum and its five related species originating from Vietnam |
| Q21284457 | Antiinflammatory and immunomodulating properties of fungal metabolites |
| Q92755587 | Attenuated Total Reflection-Fourier Transform Infrared Spectroscopy (ATR-FTIR) Combined with Chemometrics Methods for the Classification of Lingzhi Species |
| Q105130695 | Chemotaxonomy of Triterpenoid Pattern of HPLC ofGanoderma lucidumandGanoderma tsugae |
| Q24673217 | Differentiation and grouping of isolates of the Ganoderma lucidum complex by random amplified polymorphic DNA-PCR compared with grouping on the basis of internal transcribed spacer sequences |
| Q34559076 | Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors |
| Q46610285 | Effects on tyrosinase activity by the extracts of Ganoderma lucidum and related mushrooms |
| Q55007390 | Enhanced production of polysaccharides and triterpenoids in Ganoderma lucidum fruit bodies on induction with signal transduction during the fruiting stage. |
| Q24185921 | Ganoderma lucidum(Reishi mushroom) for cancer treatment |
| Q64896746 | Hyperproduction of exopolysaccharides by submerged mycelial culture of Ganoderma lucidum using a solid seed grown in fine-powder of wheat bran and in vitro evaluation of the antioxidant activity of the exopolysaccharides produced. |
| Q41848668 | Hypoglycemic Effects of Exo-biopolymers Produced by Five Different Medicinal Mushrooms in STZ-induced Diabetic Rats |
| Q38786899 | Identification of Potential Anticancer Activities of Novel Ganoderma lucidum Extracts Using Gene Expression and Pathway Network Analysis |
| Q29896490 | Identification of commercial Ganoderma (Lingzhi) species by ITS2 sequences |
| Q36510639 | Indian medicinal mushrooms as a source of antioxidant and antitumor agents |
| Q55229013 | Investigation of lignocellulolytic enzymes during different growth phases of Ganoderma lucidum strain G0119 using genomic, transcriptomic and secretomic analyses. |
| Q39484101 | Lignin-modifying enzymes of the white rot basidiomycete Ganoderma lucidum |
| Q35646733 | Medicinal mushrooms: Towards a new horizon |
| Q92444423 | Meroterpenoids from the Fungus Ganoderma sinensis and First Absolute Configuration Clarification of Zizhine H |
| Q87081717 | Mushroom nutriceuticals |
| Q78231479 | New Triterpenoids from the Fruiting Bodies ofGanoderma lucidumand Their Bioactivities |
| Q42562794 | Optimal Culture Conditions for Mycelial Growth and Exo-polymer Production of Ganoderma applanatum |
| Q91643034 | Optimization of submerged culture conditions involving a developed fine powder solid seed for exopolysaccharide production by the medicinal mushroom Ganoderma lucidum |
| Q37126696 | Physicochemical Requirement for the Vegetative Growth of Schizophyllum commune Collected from Different Ecological Origins |
| Q89861747 | Sensory and Chemical Drivers of Wine Consumers' Preference for a New Shiraz Wine Product Containing Ganoderma lucidum Extract as a Novel Ingredient |
| Q28543440 | The effects of orally administered Beta-glucan on innate immune responses in humans, a randomized open-label intervention pilot-study |
| Q37749613 | The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis. |
| Q34387512 | The species identity of the widely cultivated Ganoderma, 'G. lucidum' (Ling-zhi), in China |
| Q37987758 | Triterpenoids from the spores of Ganoderma lucidum |
Search more.